Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Condition:   T Cell Lymphoma Intervention:   Drug: Tenalisib Sponsor:   Rhizen Pharmaceuticals SA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials